CIPO Patents = 2

EPO Patents = 2

Trademarks = 1

Forward Citations = 7

Loading Chart...

1 inventor (with patents filed for the assignee):

Bin Wu (5 out of 45 patents)

5 patents: Sort by Forward Citations

1. 11439594 - Microparticles and nanoparticles having negative surface charges (2022-09-13),

2. 10780053 - Microparticles and nanoparticles having negative surface charges (2020-09-22),

3. 10702476 - Microparticle formulations of adenosine receptor antagonists for treating cancer (2020-07-07),

4. 10675350 - Nanoparticles of indirubin, derivatives thereof and methods of making and using same (2020-06-09),

5. 10039829 - Nanoparticles of indirubin, derivatives thereof and methods of making and using same (2018-08-07),

Company Overview

Phosphorex, Inc. is a leading provider of drug delivery solutions for the biotechnology industry. With a focus on innovative technologies, Phosphorex offers a range of services including formulation development, preclinical studies, and regulatory support. Their expertise in nanoparticle-based delivery systems allows for targeted and controlled release of pharmaceutical compounds, improving efficacy and patient outcomes.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

5 Patents

#18 in Hopkinton, MA

#2,894 in Massachusetts

#51,620 in US

Hopkinton, MA, United States of America

Phosphorex, Inc.

Forward Citations = 7

1 inventor:

Bin Wu (5 out of 45 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Phosphorex, Inc.. Retrieved from https://idiyas.com/company/phosphorex

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]